Stocks
MAPLEBEAR INC. CMNMBR
YHDHealthcareBiotechnology
A specialty pharmaceutical company focused on developing and commercializing innovative therapies for unmet medical needs. Its lead product candidates target rare diseases and niche therapeutic areas, with a pipeline that has attracted investor attention for its potential in high-value markets. The company's progress through clinical trials and regulatory milestones is closely watched by investors seeking exposure to the biotech sector.
52W Range: $2.96-$2.96
Congressional Interest in MAPLEBEAR INC. CMN (MBR)
1 member of Congress has disclosed 2 trades in MAPLEBEAR INC. CMN (MBR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading MBR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-07-13 | Rohit Khanna | buy | $1K-$15K |
| 2026-07-13 | Rohit Khanna | sell | $1K-$15K |